Latest Articles
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - BIOENGINEER.ORG
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment BIOENGINEER.ORG
Published: Jan. 19, 2026, 3:06 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - Bioengineer.org
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment Bioengineer.org
Published: Jan. 19, 2026, 3:06 p.m.
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis.
Endometriosis affects over 190 million women globally, and effective therapies are urgently needed to address the burden of endometriosis on women's health. Using an artificial intelligence (AI)-driven target discovery platform, …
Published: Dec. 12, 2024, midnight
Link copied to clipboard!